Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug Read more →
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates Read more →
Amgen sheds around 40 staffers amid continuing struggles Read more →
